Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Schmidt, HH; Renner, H; Linkesch, W.
Intrapleural instillation of rituximab for the treatment of malignant pleural effusions in NHL.
Haematologica. 2004; 89(11): ECR39-ECR39. (- Case Report) [OPEN ACCESS]
PubMed Google Scholar

 

Führende Autor*innen der Med Uni Graz
Schmidt Helmut
Co-Autor*innen der Med Uni Graz
Linkesch Werner
Renner Heiko
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
A patient with CD20(+) leukaemic lymphoplasmacytic Non-Hodgkin's lymphoma (NHL) presented with bilateral malignant pleural effusions. Systemic chemotherapy, repeated percutaneous drainage and bilateral continous chest tube drainage were unable to control the effusions. Rituximab was instilled in a dose-escalating manner via the chest tubes into both pleural spaces, within two weeks the effusions resolved, and the patient has stayed free of symptoms for eight months ongoing. Rituximab may be a promising novel treatment option for malignant effusions in CD20(+) NHL.
Find related publications in this database (using NLM MeSH Indexing)
Antibodies, Monoclonal - therapeutic use
Antigens, CD20 - immunology
Antineoplastic Agents - therapeutic use
Humans -
Instillation, Drug -
Lymphoma, Non-Hodgkin - complications Lymphoma, Non-Hodgkin - drug therapy Lymphoma, Non-Hodgkin - immunology
Male -
Middle Aged -
Pleura - drug effects
Pleural Effusion, Malignant - drug therapy Pleural Effusion, Malignant - etiology Pleural Effusion, Malignant - immunology

© Med Uni Graz Impressum